NVIDIA has been forgotten among the broader semiconductor story, but its returns have been entirely driven by earnings while its valuation has contracted, creating ignored value.
Healthcare has not participated as much in the rally, is not as stretched from a valuation standpoint, and offers added defensiveness in a market like this, making it an attractive area.